Current
7.9×
5-Year Average
9.9×
All-Time High
16.2×
All-Time Low
1.9×
P/S Ratio daily chart for Edwards Lifesciences (EW)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Edwards Lifesciences (EW) from 2001 to 2025
| 2025 | $49.48B | $6.07B | 8.2× | +0.2× | |
| 2024 | $43.66B | $5.46B | 8.0× | -0.8× | |
| 2023 | $46.15B | $5.26B | 8.8× | +0.3× | |
| 2022 | $45.73B | $5.38B | 8.5× | -7.0× | |
| 2021 | $80.85B | $5.23B | 15.5× | +2.5× | |
| 2020 | $56.88B | $4.39B | 13.0× | +1.8× | |
| 2019 | $48.71B | $4.35B | 11.2× | +2.6× | |
| 2018 | $31.87B | $3.72B | 8.6× | +1.6× | |
| 2017 | $23.76B | $3.44B | 6.9× | +0.2× | |
| 2016 | $20.02B | $2.96B | 6.8× | -0.1× | |
| 2015 | $17.04B | $2.49B | 6.8× | +0.9× | |
| 2014 | $13.68B | $2.32B | 5.9× | +2.4× | |
| 2013 | $7.18B | $2.05B | 3.5× | -1.9× | |
| 2012 | $10.37B | $1.90B | 5.5× | +0.7× | |
| 2011 | $8.07B | $1.68B | 4.8× | -1.5× | |
| 2010 | $9.18B | $1.45B | 6.3× | +2.6× | |
| 2009 | $4.90B | $1.32B | 3.7× | +1.2× | |
| 2008 | $3.07B | $1.24B | 2.5× | +0.1× | |
| 2007 | $2.61B | $1.09B | 2.4× | -0.2× | |
| 2006 | $2.71B | $1.04B | 2.6× | +0.1× | |
| 2005 | $2.48B | $997.90M | 2.5× | -0.2× | |
| 2004 | $2.46B | $931.50M | 2.6× | +0.6× | |
| 2003 | $1.78B | $860.50M | 2.1× | -0.1× | |
| 2002 | $1.50B | $704.00M | 2.1× | -0.2× | |
| 2001 | $1.63B | $692.00M | 2.4× | — |
- 20258.2×
- 20248.0×
- 20238.8×
- 20228.5×
- 202115.5×
- 202013.0×
- 201911.2×
- 20188.6×
- 20176.9×
- 20166.8×
- 20156.8×
- 20145.9×
- 20133.5×
- 20125.5×
- 20114.8×
- 20106.3×
- 20093.7×
- 20082.5×
- 20072.4×
- 20062.6×
- 20052.5×
- 20042.6×
- 20032.1×
- 20022.1×
- 20012.4×
About P/S Ratio at Edwards Lifesciences (EW)
Edwards Lifesciences (EW) P/S ratio is 7.9× as of June 5, 2026. The 5-year average is 9.9×. The sector median currently stands at 3.5×. The current ratio is at the 19th percentile of its own 10-year history.
Edwards Lifesciences (EW) historical P/S ratio has ranged from a low of 1.9× (2003) to a high of 16.2× (2021) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Edwards Lifesciences P/S Ratio by Year
Edwards Lifesciences P/S Ratio 2025: 8.2×
Edwards Lifesciences (EW) P/S ratio in 2025 was 8.2×, expanded from 8.0× the prior year.
Edwards Lifesciences P/S Ratio 2024: 8.0×
Edwards Lifesciences (EW) P/S ratio in 2024 was 8.0×, contracted from 8.8× the prior year.
Edwards Lifesciences P/S Ratio 2023: 8.8×
Edwards Lifesciences (EW) P/S ratio in 2023 was 8.8×, expanded from 8.5× the prior year.
Edwards Lifesciences P/S Ratio 2022: 8.5×
Edwards Lifesciences (EW) P/S ratio in 2022 was 8.5×, contracted from 15.5× the prior year.
Edwards Lifesciences P/S Ratio 2021: 15.5×
Edwards Lifesciences (EW) P/S ratio in 2021 was 15.5×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Edwards Lifesciences (EW), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric